CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC (CASBF) Stock Price, Quote, News & History

Key Statistics

Open

Volume / Avg.

0 / 611.00

Day Range

- - -

52 Wk Range

2.60 - 6.99

Market Cap

P/E Ratio

277.45

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

Recent CanSino Biologics Inc. News

Current Updates On COVID-19 Vaccines

Besides saving lives and the global economy, we are expecting three things from the upcoming COVID-19 vaccine: safety, immunogenicity and efficacy. But we never had a 100 percent efficacy when it comes to respiratory viruses, so anything between 50 and 100% will be the best we've got as the WHO believes everything above 50 percent efficacy is acceptable.

IAM Newswire

CanSino, Canada End COVID-19 Vaccine Collaboration, Citing Chinese Bureaucratic Hurdles

CanSino Biologics Inc (OTC: CASBF) partnership with Canada’s National Research Council on a COVID-19 vaccine came to an end Wednesday, Reuters

Shivdeep Dhaliwal

A Peek Into The Markets: US Stock Futures Rise Following Prior Week's Gains

Pre-open movers U.S. stock futures traded higher in early pre-market trade, after recording gains in the previous week. The Empire State manufacturing index for August is scheduled for release at 8:30 a.m. ET, while the NAHB’s housing market index for August will be released at 10:00 a.m. ET.

Lisa Levin

CanSino Gets China's First COVID-19 Vaccine Patent

CanSino Biologics Inc (OTC: CASBF) has become the first company to secure a patent for its COVID-19 vaccine in China, Reuters

Shivdeep Dhaliwal

CanSino Biologics Shares Rose 380% As COVID-19 Vaccine Promise Emerges

CanSino Biologics Inc. (OTC: CASBF), a Chinese vaccine maker, has emerged as the rising star of the Hong Kong market, after its COVID-19 clinical trial application was approved by Health Canada, the country's federal health policy department.

Shivdeep Dhaliwal

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

77.86M

Investing Cash Flow (TTM)

364.80M

Financing Cash Flow (TTM)

-766.22M

Free Cash Flow (TTM)

-166.04M

Capital Expenditure (TTM)

-243.90M

Net Change in Cash (TTM)

-323.56M

Valuation Metrics

Enterprise Value

$1.86B

PE Ratio (TTM)

277.45

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

7.12

PB Ratio (TTM)

1.52

Earnings Yield % (TTM)

0.36%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

52.56

Price / EBITDA (TTM)

31.67

Price / Free Cash Flow (TTM)

Book Value / Share

$2.98

Company Debt

Total Debt

$1.28B

LT Debt

$956.95M

LT Debt Issuance (TTM)

$795.66M

LT Debt Repayment (TTM)

-$1.51B

Total Cash

$1.22B

Debt to Equity

0.26

Issuance of Debt (TTM)

-$714.40M

Repayment of Debt (TTM)

-$1.51B

Key Statistics

Open

Volume / Avg.

0 / 611.00

Day Range

- - -

52 Wk Range

2.60 - 6.99

Market Cap

P/E Ratio

277.45

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

About

Sector

Health Care

Industry

Biotechnology

CanSino Biologics Inc is engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. The company has a broad portfolio of vaccines and vaccine candidates for several disease areas. Its commercial-s...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

CASBF

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

CASBF

FAQ

How do I buy CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC (CASBF) stock?

You can purchase shares of CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC (OTCPK:CASBF) through any online brokerage.

View our list of the best stock brokerages

Who are CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC (CASBF) competitors?

There are no as such competitors for CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC.

What is the forecast, or price target, for CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC (CASBF) stock?

There is no analysis for CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC to provide a consensus price target.

What is the current price for CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC (CASBF)?

The stock price for CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC (OTCPK: CASBF) is $4.54 last updated August 26, 2026 at 11:12 AM EDT.

Does CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC (CASBF) pay a dividend?

There are no upcoming dividends for CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC.

When is CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC (OTCPK:CASBF) reporting earnings?

CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC does not have any upcoming earnings scheduled.

Is CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC (CASBF) going to split?

There is no upcoming split for CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC.

What sector and industry does CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC (CASBF) operate in?

CANSINO BIOLGICS REG H by CANSINO BIOLOGICS INC is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.